After binding HER2, the ADC is internalized and its cleavable linker releases a camptothecin-derived topoisomerase I inhibitor that stabilizes TOP1-DNA complexes, causing DNA breaks, replication arrest, and apoptosis in HER2-expressing cells (with potential bystander killing).